MedPath

A Clinical Study to see the effect of Febrikid Suspension in Fever in children.

Phase 2
Conditions
Health Condition 1: B999- Unspecified infectious disease
Registration Number
CTRI/2022/04/041681
Lead Sponsor
Department of Kaumarbhritya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient of either gender suffering from fever of age 3-10 years.

2. Acute onset of fever of 1 to 3 days.

3. Temperature between 99-102 Fahrenheit.

4. Children with parents who agree to participate and sign the informed consent.

Exclusion Criteria

1. Fever more than 102 Fahrenheit.

2. Chronic fever associated with infective disorder.

3. Fever more than 3 days and diagnosed with malaria, dengue, typhoid, pneumonia etc.

4. Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator as non induceable will be excluded from study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in FeverTimepoint: 5 Days
Secondary Outcome Measures
NameTimeMethod
To assess improvement in associated symptoms of Fever according to Ayurveda Classics everyday.Timepoint: 5 Days
© Copyright 2025. All Rights Reserved by MedPath